MENU
+Compare
WINT
Stock ticker: NASDAQ
AS OF
Jul 14, 12:44 PM (EDT)
Price
$0.82
Change
+$0.09 (+12.33%)
Capitalization
2.67M

WINT Windtree Therapeutics Inc. Forecast, Technical & Fundamental Analysis

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases... Show more

Industry: #Biotechnology
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for WINT with price predictions
Jul 11, 2025

WINT's RSI Indicator recovers from overbought zone

The 10-day RSI Oscillator for WINT moved out of overbought territory on July 07, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 instances where the indicator moved out of the overbought zone. In of the 17 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 27 cases where WINT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

WINT moved below its 50-day moving average on July 09, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WINT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

WINT broke above its upper Bollinger Band on July 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for WINT entered a downward trend on June 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 02, 2025. You may want to consider a long position or call options on WINT as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for WINT just turned positive on June 30, 2025. Looking at past instances where WINT's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a +6 3-day Advance, the price is estimated to grow further. Considering data from situations where WINT advanced for three days, in of 202 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.260) is normal, around the industry mean (17.292). P/E Ratio (0.826) is within average values for comparable stocks, (58.926). WINT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.456). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (272.270).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. WINT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WINT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

WINT is expected to report earnings to fall 2,725.00% to -1050 cents per share on May 17

Windtree Therapeutics Inc. WINT Stock Earnings Reports
Q1'23
Est.
$-10.50
Q4'24
Beat
by $0.75
Q4'22
Missed
by $2.48
Q3'22
Beat
by $0.13
Q2'22
Missed
by $0.41
The last earnings report on April 15 showed earnings per share of 40 cents, beating the estimate of -34 cents. With 8.59M shares outstanding, the current market capitalization sits at 2.67M.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2600 Kelly Road
Phone
+1 215 488-9300
Employees
20
Web
https://www.windtreetx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRT9.72-0.02
-0.26%
Cross Timbers Royalty Trust
ASND174.96-1.53
-0.87%
Ascendis Pharma A/S
FRME40.99-0.60
-1.44%
First Merchants Corp
THFF55.59-1.12
-1.97%
First Financial Corp
NUWE6.88-0.57
-7.59%
Nuwellis Inc

WINT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, WINT has been loosely correlated with MLEC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if WINT jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WINT
1D Price
Change %
WINT100%
+12.31%
MLEC - WINT
49%
Loosely correlated
-12.82%
DVHGF - WINT
37%
Loosely correlated
N/A
INMB - WINT
31%
Poorly correlated
+4.04%
CDTX - WINT
27%
Poorly correlated
-0.68%
VRAX - WINT
27%
Poorly correlated
+1.11%
More